The New York based Pfizer Inc (NYSE:PFE) estimate profit of around $2.30 per share in fiscal year 2013, over analyst forecasts after the launch of 2 products with the potential to each generate over $1 billion a year.
The world’s biggest drug maker announced in a statement that full-year earnings without special items are anticipated to be $2.20 to $2.30 per share. The top of the estimate range was over the $2.28 median of 19 analysts’ forecasts gathered by Bloomberg. Drug giant’s fiscal fourth-quarter profit tops analyst forecasts.
The drug giant announced fiscal Q4 net income more than quadrupled to $6.32 billion or 85 cents per share, from $1.44 billion or 19 cents per share in previous year.
Its competitors include Novartis AG (ADR) (NYSE:NVS) that rose +0.58% to $67.95 with the total traded volume of 380,660.00 million shares and Sanofi SA (ADR) (NYSE:SNY) that dropped -0.29% to $48.78 with the total traded volume of 380,041.00 shares.
Other Healthcare stocks with bullish trend include Boston Scientific Corporation (NYSE:BSX) up +4.88% to $7.20, Keryx Biopharmaceuticals (NASDAQ:KERX) up 37.85% to $8.33 and Johnson & Johnson (NYSE:JNJ) up 0.54% to $74.02, whereas with bearish trend include Anacor Pharmaceuticals Inc (NASDAQ:ANAC) down -19.20% to $4.18, Bristol Myers Squibb Co (NYSE:BMY) down -0.05% to $36.39 and Arena Pharmaceuticals, Inc (NASDAQ:ARNA) down -1.50% to $8.43.
Pfizer Inc (NYSE:PFE) stock reports on Jan 29, 2013 increased 2.35% to the trading price of $27.48. Its fifty two week range is $20.75-$27.52. The total market capitalization remained $202.25 billion.
The overall volume in the current trading session is 11.67 million shares. In its share capital PFE has 7.36 billion outstanding shares among them 7.36 billion shares have been floated in market exchange. PFE stock institutional ownership remained 72.92% while insider ownership included 0.02%.
PFE is ahead its 52 week low with 36.08% and going forward from its 52 week high price with 0.56%. PFE last month stock price volatility remained 1.26%. The stock price of PFE is moving forward from its 20 days moving average with 4.22% and remote positively from 50 days moving average with 7.64%.
PFE current year earnings per share experienced an addition with 9.08% while its current quarter performance remained 7.49%. Company’s beta coefficient included 0.74. Beta factors measures the amount of market risk associated with market trade.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL